Compounds, compositions and methods are provided for modulating the
expression of apolipoprotein(a). The compositions comprise
oligonucleotides, targeted to nucleic acid encoding apolipoprotein(a).
Methods of using these compounds for modulation of apolipoprotein(a)
expression and for diagnosis and treatment of disease associated with
expression of apolipoprotein(a) are provided.